alias:: Muscle Weakness, Paresis
ICD-11_Code::   MB48 (Muscle weakness), 8B03 (Hemiplegia), 8B60 (Mononeuropathy)
tags:: symptom, sign, clinical presentation

- #definition  
  > *A reduction in voluntary muscle strength, which may be subjectively reported or objectively observed, often reflecting dysfunction of the nervous system (CNS, PNS, NMJ, or muscles) or systemic illness.*
- > Cardinal Presentation of Neurological Diseases  
  *2 questions one must generally determine, 1) where is the lesion? 2) what is the lesion?*
- # Presentation
	- ## Quality
		- ### Subtypes:
			- **Focal** (e.g., stroke, mononeuropathy)
			- **Generalized** (e.g., myopathy, Guillain-Barré)
			- **Proximal** (e.g., myositis) vs. **Distal** (e.g., peripheral neuropathy)
			- **Upper motor neuron (UMN)**: Spasticity, hyperreflexia (e.g., ALS, MS)
			- **Lower motor neuron (LMN)**: Flaccidity, hyporeflexia (e.g., polio, radiculopathy)
		- ### Severity Scales
			- **Medical Research Council (MRC) Scale**: 0 (no contraction) to 5 (normal power)
			- **Functional Impact**: Inability to stand (proximal) vs. grip (distal).
		- ### Timing
			- **Acute** (<72h): Stroke, spinal cord compression, botulism.
			- **Subacute**: Myasthenia gravis, inflammatory myopathy.
			- **Chronic**: ALS, muscular dystrophy.
				- insidious onset: ALS, dystrophy
- # Epidemiology
	- **Stroke**: Leading cause of unilateral weakness (prevalence ~2.5% in adults >40).
	- **Diabetic neuropathy**: 50% of diabetics after 25 years.
	- **GBS**: 1-2/100,000 annually; peaks in young adults/elderly.
	- ALS : ~2 per 100k per year
	- Myasthenia gravis : ~20 per 100k per year
- # Clinical Approach
	- Rule out Fatigue first
	- Then find out the location of lesion, then the lesion
	- Physical Exam is key for finding out the location of lesion
- # Differential Diagnosis/Classification
	- | **Type** | **Criteria** | **Differential Diagnosis (Acute / Subacute / Chronic)** |
	  | ---- | ---- | ---- | --- |
	  | **UMN** | Hyperreflexia, spasticity |**Acute**: Stroke, Spinal cord infarct <br />**Subacute**: MS relapse, Transverse myelitis <br />**Chronic**: ALS, PLS |
	  | **LMN** | Hyporeflexia, atrophy, distal weakness | **Acute**: GBS, Toxins (lead) <br />**Subacute**: CIDP, Polio <br />**Chronic**: SMA, Hereditary neuropathies |
	  | **UMN + LMN** | Combined UMN & LMN signs in different regions |**Chronic**: ALS (mixed signs) |
	  | **NMJ** | Fluctuating weakness, fatigability | **Acute**: Botulism, Myasthenic crisis <br />**Subacute**: Myasthenia gravis <br />**Chronic**: Lambert-Eaton syndrome |
	  | **Myopathic** | Proximal weakness, normal reflexes | **Acute**: Rhabdomyolysis <br />**Subacute**: Polymyositis, Steroid myopathy <br />**Chronic**: Muscular dystrophies |
	- Acute : Hours-Days
	  Subacute : Days-Weeks
	  Chronic : Months-Years
- # Associations
	- ## Associated Symptoms
		- | **Symptom**       | **Sensitivity (%)** | **Specificity (%)** | **PPV/NPV**       | **Notes**                          |  
		  |--------------------|---------------------|---------------------|-------------------|------------------------------------|  
		  | Dysphagia          | 60 (ALS)            | 85                  | High PPV for bulbar involvement | Also seen in myasthenia. |  
		  | Sensory loss       | 80 (neuropathy)     | 70                  | High NPV for myopathy | Helps differentiate LMN vs. myopathy. |
	- ## Associated Conditions
		- | **Condition**         | **Pre-test Probability** | **Key Clues**                     | **Diagnostic Criteria**              |  
		  |------------------------|--------------------------|------------------------------------|--------------------------------------|  
		  | Guillain-Barré         | Low (1-2/100,000)        | Ascending paralysis, areflexia    | CSF albuminocytologic dissociation   |  
		  | Multiple Sclerosis     | Moderate in young adults | UMN signs, optic neuritis         | McDonald Criteria (MRI/CSF)          |
- # Classification
	- | **Type**               | **Criteria**                          | **Example Cause**            |  
	  |------------------------|---------------------------------------|------------------------------|  
	  | UMN                    | Hyperreflexia, spasticity             | Stroke, MS                   |  
	  | LMN                    | Hyporeflexia, atrophy                 | radiculopathy, diabetic neuropathy           |  
	  | UMN+LMN | combined signs in different limbs, regions | ALS |
	  |NMJ | Fluctuating Weakness, fatigability | Myasthenia gravis, Lambert-Eaton |
	  | Myopathic              | Proximal weakness, normal reflexes   | Polymyositis                 |
- # Pathophysiology
	- **UMN**: Lesion in motor cortex/corticospinal tract → loss of inhibition-> hyperactive spinal reflexes and spasticity
	- **LMN**: Damage to anterior horn cells, nerve roots, or peripheral nerves -> wallarian degeneration -> muscle denervation, atrophy, hyporeflexia
	- **Neuromuscular Junction**: Impaired transmission at NMJ -> fluctuating weakness, fatigability
	- **Muscle** : Primary muscle pathology -> muscle fiber damage -> weakness with preserved reflexes
- # Diagnosis Workup
	- **History and Physical Examination**
	- **Imaging**:
		- MRI brain/spine (stroke, MS, cord compression)
		- CT angiography (if vascular cause suspected)
	- **Labs**:
		- CK (myopathy), electrolytes (hypokalemia), TSH (myxedema), AChR antibodies (myasthenia)
		- LP (GBS: albuminocytologic dissociation)
		- Muscle biopsy (suspected myopathy)
	- **Electrodiagnostics**:
		- EMG/NCS (neuropathy vs. myopathy)
		- Repetitive nerve stimulation (NMJ disorders)
- # Red Flags
	- **Emergent**:
		- Sudden onset + headache (stroke)
		- Bowel/bladder dysfunction (cord compression)
		- Respiratory failure (GBS, myasthenic crisis)
	- **Concerning**:
		- Asymmetric weakness (mass lesion)
		- Weight loss (malignancy)
- # Management
	- **Non-Pharmacologic**:
		- PT/OT for mobility/ADLs.
		- Ventilatory support (GBS/myasthenia).
	- **Pharmacologic**:
		- IVIG/steroids (inflammatory causes).
		- Pyridostigmine (myasthenia).
- # Complications
	- **Acute**: Aspiration pneumonia, DVT (immobility).
	- **Chronic**: Contractures, depression.
- # Mimics of Weakness
	- **Fatigue** (depression, anemia, chronic fatigue syndrome)
	- **Pain-limited weakness** (arthritis, bursitis)
	- **Systemic illness** (hypothyroidism, electrolyte imbalances)
	- **Functional Neurological Disorder** (conversion disorder)
- # Special Populations
	- **Pediatric**:
		- Duchenne muscular dystrophy (Gower’s sign)
		- Spinal muscular atrophy (SMA)
	- **Geriatric**:
		- Sarcopenia vs. myelopathy (cervical spondylosis)
		- Paraneoplastic syndromes (e.g., Lambert-Eaton)
- # Prognosis Indicators
	- | **Feature**          | **Favorable**               | **Poor**                     |  
	  |----------------------|----------------------------|-----------------------------|  
	  | **Recovery time**    | GBS (weeks-months)         | ALS (progressive)           |  
	  | **Treatment response** | Myasthenia (IVIG)         | Metastatic cord compression |
- # Mnemonics & Pearls
	- **UMN vs. LMN**:
		- *UMN*: "Upgoing toes, Muscles stiff, No atrophy" (Babinski, spasticity).
		- *LMN*: "Limp muscles, Missing reflexes, Atrophy" (flaccidity, fasciculations).
	- **5 D’s of Cord Compression**: Dermatomal pain, Diminished sensation, DTR changes, Downgoing plantar, Dysfunction (bowel/bladder).
- # References
	- *[[Muscle Weakness in Adults, Evaluation and Differential Diagnosis@Larson and Wilbur | 2020]]*
	- *UpToDate* (Myasthenia, GBS), *AAN Guidelines* (ALS, MS), *AAEM* (EMG/NCS).